The genetics of gestational trophoblastic disease: A rare complication of pregnancy

Cancer Genetics

Volumn 205, Issue 3, 2012, Pages 63-77

  Hoffner, Lori ^a   Surti, Urvashi ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Androgenetic hydatidiform mole; Choriocarcinoma; Genomic imprinting; Gestational trophoblastic disease; NLRP7

Indexed keywords

ANTINEOPLASTIC AGENT; MITOCHONDRIAL DNA;

ABORTION; CANCER GENETICS; CHORIOCARCINOMA; CHROMOSOME ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DIPLOIDY; DRUG SENSITIVITY; ECHOGRAPHY; EPITHELIOID TROPHOBLASTIC TUMOR; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENE MUTATION; GENOME IMPRINTING; GENOTYPE; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; INCIDENCE; PLACENTAL SITE TROPHOBLASTIC TUMOR; PREGNANCY; PRIORITY JOURNAL; REVIEW; TRIPLOIDY; TROPHOBLASTIC TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; CHILD; CHORIOCARCINOMA; FEMALE; GENOMIC IMPRINTING; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; HYDATIDIFORM MOLE; MIDDLE AGED; PREGNANCY; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84860230336     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.01.004     Document Type: Review

References (177)

1. Sebire N.J., Seckl M.J. Gestational trophoblastic disease: current management of hydatidiform mole. BMJ 2008, 337:1193.
2. Bower M., Newlands E.S., Holden L., et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997, 15:2636-2643.
3. Marsh J.W., Esquivel C.O., Makowka L., et al. Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987, 44:449-450.
4. Penn I. Transmission of cancer from organ donors. Nefrologia 1995, 15:205-207.
5. Kajii T., Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977, 268:633-634.
6. Vassilakos P., Riotton G., Kajii T. Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol 1977, 127:167-170.
7. Wake N., Takagi N., Sasaki M. Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst 1978, 60:51-57.
8. Jacobs P.A., Hassold T.J., Matsuyama A.M., et al. Chromosome constitution of gestational trophoblastic disease. Lancet 1978, 2:49.
9. Lawler S.D., Pickthall V.J., Fisher R.A., et al. Genetic studies of complete and partial hydatidiform moles. Lancet 1979, 2:580.
10. Jacobs P.A., Wilson C.M., Sprenkle J.A., et al. Mechanism of origin of complete hydatidiform moles. Nature 1980, 286:714-716.
11. Lawler S.D., Povey S., Fisher R.A., et al. Genetic studies on hydatidiform moles. II. The origin of complete moles. Ann Hum Genet 1982, 46(Pt 3):209-222.
12. Surani M.A., Barton S.C., Norris M.L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 1984, 308:548-550.
13. Barton S.C., Surani M.A., Norris M.L. Role of paternal and maternal genomes in mouse development. Nature 1984, 331:374-376.
14. McGrath J., Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 1984, 37:179-183.
15. Szulman A., Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphological correlations. Am J Obstet Gynaecol 1978, 13:665-671.
16. Szulman A.E., Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978, 132:20-27.
17. Surti U., Szulman A.E., O'Brien S. Complete (classic) hydatidiform mole with 46, XY karyotype of paternal origin. Hum Genet 1979, 51:153-155.
18. Fisher R.A., Povey S., Jeffreys A.J., et al. Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum Genet 1989, 82:259-263.
19. Kovacs B.W., Shahbahrami B., Tast D.E., et al. Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet 1991, 54:143-152.
20. Lawler S.D., Fisher R.A., Dent J. A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol 1991, 164:1270-1277.
21. Wallace D.C., Surti U., Adams C.W., et al. Moles have paternal chromosomes but maternal mitochondrial DNA. Hum Genet 1982, 61:145-147.
22. Edwards Y.H., Jeremiah S.J., McMillan S.L., et al. Complete hydatidiform moles combine maternal mitochondria with a paternal nuclear genome. Ann Hum Genet 1984, 48(Pt 2):119-127.
23. Golubovsky M.D. Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod 2003, 18:236-242.
24. Ford J.H., Brown J.K., Lew W.Y., et al. Diploid complete hydatidiform mole, mosaic for normally fertilized cells and androgenetic homozygous cells. Case report. Br J Obstet Gynaecol 1986, 93:1181-1186.
25. Weaver D.T., Fisher R.A., Newlands E.S., et al. Amniotic tissue in complete hydatidiform moles can be androgenetic. J Pathol 2000, 191:67-70.
26. Makrydimas G., Sebire N.J., Thornton S.E., et al. Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. Hum Reprod 2002, 17:2459-2463.
27. Surti U., Hill L.M., Dunn J., et al. Twin pregnancy with a chimeric androgenetic and biparental placenta in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 2005, 25:1048-1056.
28. Kaiser-Rogers K.A., McFadden D.E., Livasy C.A., et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006, 43:187-192.
29. Robinson W.P., Lauzon J.L., Innes A.M., et al. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 2007, 22:1114-1122.
30. Sunde L., Niemann I., Hansen E.S., et al. Mosaics and moles. Eur J Hum Genet 2011, 19:1026-1031.
31. Zaragoza M.V., Surti U., Redline R.W., et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet 2000, 66:1807-1820.
32. Sebire N.J., Fisher R.A., Rees H.C. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 2003, 6:69-77.
33. Fisher R.A., Hodges M.D., Rees H.C., et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 2002, 11:3267-3272.
34. Hoffner L., Dunn J., Esposito N., et al. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol 2008, 39:63-72.
35. Hoffner L., Parks W.T., Swerdlow S.H., et al. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies. J Reprod Med 2010, 55:219-228.
36. DeScipio C., Haley L., Beierl K., et al. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 2011 Oct, 35(10):1586-1591.
37. Fisher R.A., Nucci M.R., Thaker H.M., et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 2004, 17:1155-1160.
38. McConnell T.G., Norris-Kirby A., Hagenkord J.M., et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 2009, 33:1409-1415.
39. Sunde L., Mogensen B., Olsen S., et al. Flow cytometric DNA analyses of 105 fresh hydatidiform moles, with correlations to prognosis. Anal Cell Pathol 1996, 12:99-114.
40. Genest D.R., Dorfman D.M., Castrillon D.H. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med 2002, 47:342-346.
41. Lai C.Y., Chan K.Y., Khoo U.S., et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol 2004, 17:40-48.
42. Bifulco C., Johnson C., Hao L., et al. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 2008, 32:445-451.
43. Murphy K.M., McConnell T.G., Hafez M.J., et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn 2009, 11:598-605.
44. Ronnett B.M., DeScipio C., Murphy K.M. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol 2011, 30:101-116.
45. Berkowitz R.S., Goldstein D.P. Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases. J Reprod Med 2008, 53:455-456.
46. Boufettal H., Coulin P., Mahdaouia S., et al. Les môles hydatiformes complètes au Maroc: etude épidémiologique et clinique [Complete hydatiforme mole in Morocco: epidemiological and clinical study]. J Gyn Obst et Biologie Reprod 2011, 40:419-429.
47. Cagayan M.S. Changing trends in the management of gestational trophoblastic diseases in the Philippines. J Reprod Med 2010, 55:267-272.
48. Seckl M.J., Sebire N.J., Berkowitz R.S. Gestational trophoblastic disease. Lancet 2010, 376:717-729.
49. Vejerslev L.O., Dissing J., Hansen H.E., et al. Hydatidiform mole: genetic origin in polyploid conceptuses. Hum Genet 1987, 76:11-19.
50. Sheppard D.M., Fisher R.A., Lawler S.D., et al. Tetraploid conceptus with three paternal contributions. Hum Genet 1982, 62:371-374.
51. Surti U., Szulman A.E., Wagner K., et al. Tetraploid partial hydatidiform moles: two cases with a triple paternal contribution and a 92, XXXY karyotype. Hum Genet 1986, 72:15-21.
52. Dubé V., Chun K., Osborne R., et al. Androgenetic complete mole with trisomy 13: report of a case with microsatellite genotyping and review of the literature. Pathol Res Pract 2010, 206:776-781.
53. Surti U., Hoffner L., Kolthoff M., et al. Persistent gestational trophoblastic disease after an androgenetic/biparental fetal chimera: a case report and review. Int J Gynecol Pathol 2006, 25:366-372.
54. Shiina H., Oka K., Okane M., et al. Coexisting true hermaphroditism and partial hydatidiform mole developing metastatic gestational trophoblastic tumors. A case report. Virchows Arch 2002, 441:514-518.
55. Reed R.C., Beischel L., Schoof J., et al. Androgenetic/biparental mosaicism in an infant with hepatic mesenchymal hamartoma and placental mesenchymal dysplasia. Pediatr Dev Pathol 2008, 11:377-383.
56. H'mida D., Gribaa M., Yacoubi T., et al. Placental mesenchymal dysplasia with Beckwith-Wiedemann syndrome fetus in the context of biparental and androgenic cell lines. Placenta 2008, 29:454-460.
57. Morales C., Soler A., Badenas C., et al. Reproductive consequences of genome-wide paternal uniparental disomy mosaicism: description of two cases with different mechanisms of origin and pregnancy outcomes. Fertil Steril 2009, 92:393.e5-393.e9.
58. Hoban P.R., Heighway J., White G.R., et al. Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient. Hum Genet 1995, 95:651-656.
59. Bryke CR, Garber AT, Israel J. Evaluation of a complex phenotype in a unique patient with a paternal uniparental disomy for every chromosome cell line and a normal biparental inheritance cell line. In: Proceedings from the American Society of Human Genetics 54th Annual Meeting; October 26-30, 2004; Toronto, Canada. Abstract 823: 165.
60. Giurgea I., Sanlaville D., Fournet J.C., et al. Congenital hyperinsulinism and mosaic abnormalities of the ploidy. J Med Genet 2006, 43:248-254.
61. Wilson M., Peters G., Bennetts B., et al. The clinical phenotype of mosaicism for genomewide paternal uniparental disomy: two new reports. Am J Med Genet A 2008, 146A:137-148.
62. Romanelli V., Nevado J., Fraga M., et al. Constitutional mosaic genome-wide uniparental disomy due to diploidisation: an unusual cancer-predisposing mechanism. J Med Genet 2011, 48:212-216.
63. Yamazawa K., Nakabayashi K., Matsuoka K., et al. Androgenetic/biparental mosaicism in a girl with Beckwith-Wiedemann syndrome-like and upd(14)pat-like phenotypes. J Hum Genet 2011, 56:91-93.
64. Sarno A.P., Moorman A.J., Kalousek D.K. Partial molar pregnancy with fetal survival: an unusual example of confined placental mosaicism. Obstet Gynecol 1993, 82:716-719.
65. Ikeda Y., Jinno Y., Masuzaki H., et al. A partial hydatidiform mole with 2N/3N mosaicism identified by molecular analysis. J Assist Reprod Genet 1996, 13:739-744.
66. Zhang P., McGinniss M.J., Sawai S., et al. Diploid/triploid mosaic placenta with fetus. Towards A better understanding of 'partial moles'. Early HumDev 2000, 60:1-11.
67. Jacobs P.A., Hunt P.A., Matsuura J.S., et al. Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 1982, 89:258-266.
68. Vejerslev L.O., Fisher R.A., Surti U., et al. Hydatidiform mole: cytogenetically unusual cases and their implications for the present classification. Am J Obstet Gynecol 1987, 157:180-184.
69. Ko T.M., Hsieh C.Y., Ho H.N., et al. Restriction fragment length polymorphism analysis to study the genetic origin of complete hydatidiform mole. Am J Obstet Gynecol 1991, 164:901-906.
70. Fisher R.A., Hodges M.D. Genomic imprinting in gestational trophoblastic disease-a review. Placenta 2003, 24:S111-S118.
71. Messaed C., Chebaro W., Roberto R.B., et al. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet 2011, 48:540-548.
72. Berkowitz R.S., Im S.S., Bernstein M.R., et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1998 Jan, 43:81-86.
73. Horn L.C., Kowalzik J., Bilek K., et al. Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol 2006, 128:10-14.
74. Ambani L.M., Vaidya R.A., Rao C.S., et al. Familial occurrence of trophoblastic disease - report of recurrent molar pregnancies in sisters in three families. Clin Genet 1980, 18:27-29.
75. Parazzini F., La Vecchia C., Franceschi S., et al. Familial trophoblastic disease: case report. Am J Obstet Gynecol 1984, 149:382-383.
76. Seoud M., Khalil A., Frangieh A., et al. Recurrent molar pregnancies in a family with extensive intermarriage: report of a family and review of the literature. Obstet Gynecol 1995, 86:692-695.
77. Helwani M.N., Seoud M., Zahed L., et al. A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet 1999, 105:112-115.
78. Sensi A., Gualandi F., Pittalis M.C., et al. Mole maker phenotype: possible narrowing of the candidate region. Eur J Hum Genet 2000, 8:641-644.
79. Fisher R.A., Khatoon R., Paradinas F.J., et al. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod 2000, 15:594-598.
80. Fallahian M. Familial gestational trophoblastic disease. Placenta 2003, 24:797-799.
81. Agarwal P., Bagga R., Jain V., et al. Familial recurrent molar pregnancy: a case report. Acta Obstet Gynecol Scand 2004, 83:213-214.
82. Slim R., Fallahian M., Rivière J.B., et al. Evidence of a genetic heterogeneity of familial hydatidiform moles. Placenta 2005, 26:5-9.
83. Vejerslev L., Sunde L., Hansen B.F., et al. Hydatidiform mole and fetus with normal karyotype: support of a separate entity. Obstet Gynecol 1991, 77:868-874.
84. Sunde L., Vejerslev L.O., Jensen M.P., et al. Genetic analysis of repeated, biparental, diploid, hydatidiform moles. Cancer Genet. Cytogenet 1993, 66:16-22.
85. Al-Hussaini T.K., Abd el-Aal D.M., Van den Veyver I.B. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy. Int J Gynaecol Obstet 2003 Nov, 83:179-186.
86. Judson H., Hayward B.E., Sheridan E., et al. A global disorder of imprinting in the human female germ line. Nature 2002, 416:539-542.
87. Van den Veyver I.B., Al-Hussaini T.K. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update 2006, 12:233-242.
88. Djuric U., El-Maarri O., Lamb B., et al. Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation. Hum Genet 2006, 120:390-395.
89. El-Maarri O., Seoud M., Coullin P., et al. Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet 2003, 12:1405-1413.
90. Kou Y.C., Shao L., Peng H.H., et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod 2008, 14:33-40.
91. Hayward B.E., De Vos M., Talati N., et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat 2009, 30:E629-E639.
92. Fisher R.A., Hodges M.D., Newlands E.S. Familial recurrent hydatidiform mole: a review. J Reprod Med 2004, 49:595-601.
93. Wang C.M., Dixon P.H., Decordova S., et al. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. J Med Genet 2009, 46:569-575.
94. Moglabey Y.B., Kircheisen R., Seoud M., et al. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet 1999, 8:667-671.
95. Hodges M.D., Rees H.C., Seckl M.J., et al. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet 2003, 40:e95.
96. Panichkul P.C., Al-Hussaini T.K., Sierra R., et al. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig 2005, 12:376-383.
97. Murdoch S., Djuric U., Mazhar B., et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 2006, 38:300-302.
98. Martinon F., Gaide O., Pétrilli V., et al. NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 2007, 29:213-229.
99. Qian J., Deveault C., Bagga R., et al. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum Mutat 2007, 28:741.
100. Deveault C., Qian J.H., Chebaro W., et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet 2009, 18:888-897.
101. Puechberty J., Rittore C., Philibert L., et al. Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure. Clin Genet 2009, 75:298-300.
102. Slim R., Bagga R., Chebaro W., et al. A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation. Clin Genet 2009 Sep, 76:292-295.
103. Buyukkurt S., Fisher R.A., Vardar M.A., et al. Heterogeneity in recurrent complete hydatidiform mole: presentation of two new Turkish families with different genetic characteristics. Placenta 2010, 31:1023-1025.
104. Muhlstein J., Golfier F., Rittore C., et al. The spectrum of NLRP7 mutations in French patients with recurrent hydatidiform mole. Eur J Obstet Gynecol Reprod Biol 2011, 157:197-199.
105. Qian J., Cheng Q., Murdoch S., et al. The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes, and reproductive outcomes. Mol Hum Reprod 2011, 17:612-619.
106. Infevers. Available at: Accessed June 9, 2011. http://fmf.igh.cnrs.fr/ISSAID/infevers.
107. Slim R., Ao A., Surti U., et al. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations. Placenta 2011, 32:409-412.
108. van der Smagt J.J., Scheenjes E., Kremer J.A., et al. Heterogeneity in the origin of recurrent complete hydatidiform moles: not all women with multiple molar pregnancies have biparental moles. BJOG 2006, 113:725-728.
109. Zhao J., Moss J., Sebire N.J., et al. Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole. Hum Reprod 2006, 21:536-541.
110. Bagshawe K.D., Wilson H., Dublon P., et al. Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG). J Obstet Gynaecol Br Commonw 1973, 80:461-468.
111. Bagshawe K.D., Dent J., Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet 1986, 2:673-677.
112. Kajii T., Kurashige H., Ohama K., et al. XY and XX complete moles: clinical and morphologic correlations. Am J Obstet Gynecol 1984, 150:57-64.
113. Wake N., Seki T., Fujita H., et al. Malignant potential of homozygous and heterozygous complete moles. Cancer Res 1984, 44:1226-1230.
114. Wake N., Fujino T., Hoshi S., et al. The propensity to malignancy of dispermic heterozygous moles. Placenta 1987, 8:319-326.
115. Kaneki E., Kobayashi H., Hirakawa T., et al. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Cancer Sci 2010, 101:1717-1721.
116. Fisher R.A., Lawler S.D. Heterozygous complete hydatidiform moles: do they have a worse prognosis than homozygous complete moles?. Lancet 1984, 2:51.
117. Mutter G.L., Pomponio R.J., Berkowitz R.S., et al. Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol 1993, 168:1547-1551.
118. Cheung A.N., Sit A.S., Chung L.P., et al. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol 1994, 55:386-392.
119. van de Kaa C.A., Schijf C.P., de Wilde P.C., et al. Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value. Mod Pathol 1996, 9:1007-1014.
120. Seckl M.J., Fisher R.A., Salerno G.A., et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000, 356:36-39.
121. Sebire N.J., Makrydimas G., Agnantis N.J., et al. Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy. Anticancer Res 2003, 23:1723-1728.
122. Feltmate C.M., Growdon W.B., Wolfberg A.J., et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 2006, 51:902-906.
123. Hancock B.W., Nazir K., Everard J.E. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med 2006, 51:764-766.
124. Wielsma S., Kerkmeijer L., Bekkers R., et al. Persistent trophoblast disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol 2006, 46:119-123.
125. Niemann I., Hansen E.S., Sunde L. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol 2007, 104:411-415.
126. Genest D.R., Ruiz R.E., Weremowicz S., et al. Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med 2002, 47:363-368.
127. Jeffers M.D., O'Dwyer P., Curran B., et al. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis. Int J Gynecol Pathol 1993, 12:315-323.
128. Cheung A.N., Khoo U.S., Lai C.Y., et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer 2004, 100:1411-1417.
129. Sebire N.J., Foskett M., Paradinas F.J., et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet 2002, 359:2165-2166.
130. Gestational trophoblastic disease. World Health Organ Techl Rep Ser 1983, 692:7-81. World Health Organization Scientific Group.
131. Zhao J., Xiang Y., Wan X.R., et al. Molecular genetic analyses of choriocarcinoma. Placenta 2009, 30:816-820.
132. Lurain J.R. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011, 204:11-18.
133. Yang Y.H., Kwak H.M., Park T.K., et al. Comparative cytogenetic and clinicopathologic studies on gestational trophoblastic neoplasia, especially hydatidiform mole. Yonsei Med J 1986, 27:250-260.
134. Cheung A.N., Zhang H.J., Xue W.C., et al. Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol 2009, 5:217-231.
135. Palmer J.R. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994, 39:155-162.
136. Fisher R.A., Newlands E.S., Jeffreys A.J., et al. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 1992, 69:839-845.
137. Kohorn E.I. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. J Reprod Med 2002, 47:445-450.
138. Wake N., Tanaka K., Chapman V., et al. Chromosome and cellular origin of choriocarcinoma. Cancer Res 1981, 41:3137-3143.
139. Sasaki S., Katayama P.K., Roesler M., et al. Cytogenetic analysis of choriocarcinoma cell lines. Nippon Sanka Fujinka Gakkai Zasshi 1982, 34:2253-2256.
140. Sheppard D.M., Fisher R.A., Lawler S.D. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet 1985, 16:251-258.
141. Surti U., Habibian R. Chromosomal rearrangement in choriocarcinoma cell lines. Cancer Genet Cytogenet 1989, 38:229-240.
142. Bettio D., Giardino D., Rizzi N., et al. Chromosomal abnormalities in choriocarcinomas of the female. Cancer Genet Cytogenet 1993, 68:149-151.
143. Rodriguez E., Melamed J., Reuter V., et al. Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet 1995, 80:9-12.
144. Ishiwata I., Ishiwata C., Tsuiki A., et al. Establishment and characterization of a human gestational choriocarcinoma cell line (HOCC). Hum Cell 2004, 17:33-41.
145. Ahmed M.N., Kim K., Haddad B., et al. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma. Cancer Genet Cytogenet 2000, 116:10-15.
146. Matsuda T., Sasaki M., Kato H., et al. Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma. Oncogene 1997, 15:2773-2781.
147. Pils D., Horak P., Gleiss A., et al. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 2005, 104:2417-2429.
148. Burke B., Sebire N.J., Moss J., et al. Evaluation of deletions in 7q11.2 and 8p12-p21 as prognostic indicators of tumour development following molar pregnancy. Gynecol Oncol 2006, 103:642-648.
149. Asanoma K., Kato H., Inoue T., et al. Analysis of a candidate gene associated with growth suppression of choriocarcinoma and differentiation of trophoblasts. J Reprod Med 2004, 49:617-626.
150. Alifrangis C., Seckl M.J. Genetics of gestational trophoblastic neoplasia: an update for the clinician. Future Oncol 2010, 6:1915-1923.
151. Fisher R.A., Paradinas F.J., Newlands E.S., et al. Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 1992, 65:355-358.
152. Feltmate C.M., Genest D.R., Goldstein D.P., et al. Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 2002, 47:337-341.
153. Papadopoulos A.J., Foskett M., Seckl M.J., et al. Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 2002, 47:460-464.
154. Palmieri C., Fisher R.A., Sebire N.J., et al. Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet 2005, 366:688.
155. Kohorn E.I. Long-term outcome of placental-site trophoblastic tumours. Lancet 2009, 374:6-7.
156. Cole L.A., Khanlian S.A., Muller C.Y., et al. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006, 102:160-164.
157. Wang D., He Y., Hu Y., et al. Placental site trophoblastic tumor with unusual presentation in the uterine cervix. Eur J Obstet Gynecol Reprod Biol 2010, 148:100-101.
158. Remadi S., Lifschitz-Mercer B., Ben-Hur H., et al. Metastasizing placental site trophoblastic tumor: immunohistochemical and DNA analysis. 2 case reports and a review of the literature. Arch Gynecol Obstet 1997, 259:97-103.
159. Hui P., Wang H.L., Chu P., et al. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol 2007, 20:1055-1060.
160. Xue W.C., Guan X.Y., Ngan H.Y., et al. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer 2002, 94:2288-2294.
161. Hui P., Riba A., Pejovic T., et al. Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol 2004, 17:248-251.
162. Shih I.M., Kurman R.J. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998, 22:1393-1403.
163. Oldt R.J., Kurman R.J., Shih IeM. Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol 2002, 161:1033-1037.
164. Hamazaki S., Nakamoto S., Okino T., et al. Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol 1999, 30:1321-1327.
165. Xu M.L., Yang B., Carcangiu M.L., et al. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol 2009, 22:232-238.
166. Chilosi M., Piazzola E., Lestani M., et al. Differential expression of p57KIP2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998, 78:269-276.
167. Castrillon D.H., Sun D., Weremowicz S., Fisher R.A., et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57kip2. Am J Surg Pathol 2001, 25:1225-1230.
168. Fukunaga M. Immunohistochemical characterization of p57KIP2 expression in early hydatidiform moles. Hum Pathol 2002, 33:1188-1192.
169. Kihara M., Matsui H., Seki K., et al. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2. J Reprod Med 2005, 50:307-312.
170. Popiolek D.A., Yee H., Mittal K., et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 2006, 37:1426-1434.
171. Kato H., Wake N. Differential diagnosis between complete and partial mole using a TSSC3 antibody: correlation with DNA polymorphic marker analysis. J Reprod Med 2006, 51:861-867.
172. Saxena A., Frank D., Panichkul P., et al. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole. Placenta 2003, 24:835-842.
173. Thaker H.M., Berlin A., Tycko B., et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med 2004, 49:630-636.
174. Li H.W., Tsao S.W., Cheung A.N. Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 2002, 23:20-31.
175. Chiang S., Fazlollahi L., Nguyen A., et al. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization. J Mol Diagn 2011, 13:406-415.
176. Parry D.A., Logan C.V., Hayward B.E., et al. Mutations causing familial biparental hydatidiform mole implicate C6orf221 as a possible regulator of genomic imprinting in the human oocyte. Am J Hum Genet 2011, 89:451-458.
177. Fisher R.A., Lavery S.A., Carby A., et al. What a difference an egg makes. Lancet 2011, 378:1974.